treatment guidelines

Multiple Treatment Guideline Updates Released for Lung Cancer
Guideline Updates
Multiple Treatment Guideline Updates Released for Lung Cancer
05/19/2020
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The...
05/19/2020
Journal of Clinical Pathways
Interview
Prostate Cancer Treatment Varies Between General Population, Diagnosed Men
01/11/2019
JCP Editors
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
...
01/11/2019
Journal of Clinical Pathways
Research in Review
Does Delayed Lymph Node Biopsy Affect Survival Rates in Melanoma?
06/29/2017
JCP Editors
Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...
Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...
Recent...
06/29/2017
Journal of Clinical Pathways
Research in Review
PARP Inhibitors Crucial to the Future of Ovarian Cancer Treatment
06/12/2017
JCP Editors
The treatment landscape in the coming decade for ovarian cancers will likely feature poly ADP ribose polymerase (PARP) inhibitors in combination with other treatments, according to reports from a recent...
The treatment landscape in the coming decade for ovarian cancers will likely feature poly ADP ribose polymerase (PARP) inhibitors in combination with other treatments, according to reports from a recent...
The...
06/12/2017
Journal of Clinical Pathways
Research in Review
Standard of Care Shift in ALK-Positive Lung Cancer
06/12/2017
JCP Editors
A second-generation inhibitor delays anaplastic lymphoma kinase (ALK)-positive lung cancer growth for a median of 15 months longer and causes fewer adverse events than the current standard of care, according to a new...
A second-generation inhibitor delays anaplastic lymphoma kinase (ALK)-positive lung cancer growth for a median of 15 months longer and causes fewer adverse events than the current standard of care, according to a new...
A...
06/12/2017
Journal of Clinical Pathways
Research in Review
Polypharmacy and Inappropriate Medications Negatively Impact Older Patients With NHL
06/07/2017
JCP Editors
Older patients with non-Hodgkin lymphoma (NHL) who take potentially inappropriate medications increase the risk of adverse survival impacts, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
Older patients with non-Hodgkin lymphoma (NHL) who take potentially inappropriate medications increase the risk of adverse survival impacts, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
Older...
06/07/2017
Journal of Clinical Pathways
Research in Review
Breast Cancer HER2 Status Conversion After Neoadjuvant Chemo Guides Further Therapy
05/30/2017
JCP Editors
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
...
05/30/2017
Journal of Clinical Pathways
Research in Review
HPV Vaccine Underutilized Despite Significant Oral HPV Infection Protection
05/30/2017
JCP Editors
Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...
Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...
...
05/30/2017
Journal of Clinical Pathways
Research in Review
MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment
05/04/2017
JCP Editors
MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...
MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...
MRI...
05/04/2017
Journal of Clinical Pathways
Research in Review
International Guidelines Issued for Management of Sepsis, Septic Shock
03/15/2017
JCP Editors
The Surviving Sepsis Campaign, with the Society of Critical Care Management and the European Society of Intensive Care Medicine, published international guidelines for the management of sepsis and septic shock in...
The Surviving Sepsis Campaign, with the Society of Critical Care Management and the European Society of Intensive Care Medicine, published international guidelines for the management of sepsis and septic shock in...
The...
03/15/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use